Geneva Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Commault Systems
CVLT
|
+$39.5M |
| 2 |
Hain Celestial
HAIN
|
+$35.7M |
| 3 |
Raymond James Financial
RJF
|
+$18.9M |
| 4 |
Designer Brands
DBI
|
+$15.6M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$52.7M |
| 2 |
TechnipFMC
FTI
|
+$46.9M |
| 3 |
Teradata
TDC
|
+$45M |
| 4 |
Edwards Lifesciences
EW
|
+$35.5M |
| 5 |
Ulta Beauty
ULTA
|
+$27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.33% |
| 2 | Consumer Discretionary | 19.51% |
| 3 | Technology | 16.12% |
| 4 | Financials | 10.49% |
| 5 | Healthcare | 6.92% |
Similar funds
Geneva Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Geneva Capital Management held 143 positions worth $4.41B, up 4.8% from $4.21B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Capital Management withdrew a net $134M in Q4 2013, closing 9 positions and reducing 78 holdings. Its most notable exit was Tapestry, an estimated $52.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Geneva Capital Management opened a new position in Commault Systems worth $37.8M.
- Geneva Capital Management's largest Q4 2013 buy was Commault Systems: 504,320 shares worth $37.8M.
- Geneva Capital Management added most to Designer Brands in Q4 2013, an estimated $15.6M increase.
- Geneva Capital Management's biggest Q4 2013 reduction was Ulta Beauty, cutting an estimated $27M.
- Geneva Capital Management fully exited Tapestry in Q4 2013, selling an estimated $52.7M.
- Geneva Capital Management's ten largest holdings make up 21% of its $4.41B portfolio in Q4 2013.
- Geneva Capital Management opened 8 new positions and closed 9 in Q4 2013.
- Geneva Capital Management's portfolio value rose 4.8% quarter-over-quarter to $4.41B.
Based on Geneva Capital Management's 13F filing for Q4 2013, filed 11 Feb 2014.